I agree that this site is using cookies. You can find further informations here.
X
Satouchi, Miyako
163  results:
Search for persons X
?
1

Phase 1 study of pembrolizumab plus chemotherapy in Japanes..:

Nogami, Naoyuki ; Tokito, Takaaki ; Zenke, Yoshitaka...
Investigational New Drugs.  42 (2024)  1 - p. 136-144 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Phase II Study of the Liposomal Formulation of Eribulin (E7..:

Nishio, Makoto ; Murakami, Shuji ; Kawakami, Hisato...
Cancer Research Communications.  4 (2024)  1 - p. 226-235 , 2024
Link: https://doi.org/10.1158/..
 
?
3

Long-term follow-up and exploratory analysis of lenvatinib ..:

Niho, Seiji ; Sato, Jun ; Satouchi, Miyako...
Lung Cancer.  191 (2024)  - p. 107557 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Phase 2 trial of crizotinib in Japanese patients with advan..:

Nosaki, Kaname ; Yoh, Kiyotaka ; Toyozawa, Ryo...
International Journal of Clinical Oncology.  29 (2024)  8 - p. 1142-1151 , 2024
Link: https://doi.org/10.1007/..
 
?
5

Five-Year Survival Outcomes After Carbon-Ion Radiotherapy f..:

Kubo, Nobuteru ; Suefuji, Hiroaki ; Nakajima, Mio...
Journal of Thoracic Oncology.  19 (2024)  3 - p. 491-499 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Proton and carbon ion radiotherapy for operable early-stage..:

Harada, Hideyuki ; Suefuji, Hiroaki ; Mori, Keita...
Radiotherapy and Oncology.  198 (2024)  - p. 110385 , 2024
Link: https://doi.org/10.1016/..
 
?
7

KEYNOTE-434 part B: A phase 1 study evaluating the combinat..:

Yamamoto, Noboru ; Satouchi, Miyako ; Doi, Toshihiko...
Investigational New Drugs.  42 (2024)  3 - p. 261-271 , 2024
Link: https://doi.org/10.1007/..
 
?
8

Supplemental Table 1 from Phase II Study of the Liposomal F..:

Makoto Nishio ; Shuji Murakami ; Hisato Kawakami...
doi:10.1158/2767-9764.25103047.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
9

Supplemental Methods from Phase II Study of the Liposomal F..:

Makoto Nishio ; Shuji Murakami ; Hisato Kawakami...
doi:10.1158/2767-9764.25103050.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
10

Supplemental Figure 3 from Phase II Study of the Liposomal ..:

Makoto Nishio ; Shuji Murakami ; Hisato Kawakami...
doi:10.1158/2767-9764.25103056.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
11

Supplemental Table 4 from Phase II Study of the Liposomal F..:

Makoto Nishio ; Shuji Murakami ; Hisato Kawakami...
doi:10.1158/2767-9764.25103038.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
12

Supplemental Table 4 from Phase II Study of the Liposomal F..:

Makoto Nishio ; Shuji Murakami ; Hisato Kawakami...
doi:10.1158/2767-9764.25103038.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
13

FIGURE 4 from Phase II Study of the Liposomal Formulation o..:

Makoto Nishio ; Shuji Murakami ; Hisato Kawakami...
doi:10.1158/2767-9764.25103065.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
14

Supplemental Figure 1 from Phase II Study of the Liposomal ..:

Makoto Nishio ; Shuji Murakami ; Hisato Kawakami...
doi:10.1158/2767-9764.25103062.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
15

TABLE 1 from Phase II Study of the Liposomal Formulation of..:

Makoto Nishio ; Shuji Murakami ; Hisato Kawakami...
doi:10.1158/2767-9764.25103032.v1.  , 2024
Link: https://doi.org/10.1158/..
 
1-15